Quest Diagnostics Incorporated has seen a surge in stock ownership as major market players like
QRG Capital Management Inc., and
SG Americas Securities LLC have significantly increased their shareholdings. The company has identified several opportunities for growth and innovation as it continues to acquire new assets and companies. The firm recently announced its plans to acquire
LifeLabs from OMERS, bringing
advanced diagnostic services to Canadians, and erstwhile
OhioHealth's lab services. This follows a series of successful acquisitions, such as purchasing select
PathAI Diagnostics' lab assets to accelerate the adoption of AI and digital pathology in cancer diagnosis, and Allina Health. The company's recent performance has been strong, with
Q2 earnings exceeding estimates and plans to raise its 2024 outlook. Investors appreciate its value stock thanks to various acquisitions and strategic collaborations, including with
Instacart to fight food insecurity in the United States. Aside from financial growth, Quest Diagnostics has made significant strides in
corporate responsibility and
inclusion, being recognized as a 'Best Place to Work for Disability Inclusion' for the seventh consecutive year. Meanwhile, the firm also plans to expand in Canada with its nearly
$1 billion LifeLabs deal.
Quest Diagnostics DGX News Analytics from Mon, 08 Jan 2024 08:00:00 GMT to Sun, 11 Aug 2024 16:18:08 GMT -
Rating 8
- Innovation 6
- Information 7
- Rumor -4
